Eden Research (LON:EDEN) Shares Down 3.3% – Here’s What Happened

Eden Research plc (LON:EDEN)’s share price traded down 3.3% during mid-day trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares changed hands during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The firm has a market cap of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The business’s fifty day simple moving average is GBX 3.87 and its 200-day simple moving average is GBX 3.95. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26.

Insider Buying and Selling

In related news, insider Lykele van der Broek acquired 256,000 shares of the firm’s stock in a transaction on Thursday, February 6th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey bought 540,540 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). 14.02% of the stock is owned by insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.